Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 151 results.
User Information
Export Records
  1. 1.   Exploration of Ultralarge Compound Collections for Drug Discovery
  2. Warr, Wendy A; Nicklaus,Marc; Nicolaou, Christos A; Rarey, Matthias
  3. Journal of Chemical Information and Modeling. 2022, Apr 14;
  1. 2.   Regulatory roles of galectins on influenza A virus and their potential as a therapeutic strategy
  2. Yang, Zih-Syuan; Lin, Chih-Yen; Huang,Szu-Wei; Wang, Wen-Hung; Urbina, Aspiro Nayim; Tseng, Sung-Pin; Lu, Po-Liang; Chen, Yen-Hsu; Wang, Sheng-Fan
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021, Jul; 139
  1. 3.   Moving towards an evidence-informed cancer control strategy: A scoping review of oncology research in Kenya
  2. Manduku, Veronica; Akhavan, Mina; Asiki, Gershim; Brand, Nathan R.; Cira,Mishka; Gura, Zeinab; Kadengye, Damazo T.; Karagu, Alfred; Livinski, Alicia A.; Meme, Helen; Kyobutungi, Catherine
  3. JOURNAL OF CANCER POLICY. 2020, JUN; 24: 100219.
  1. 4.   Autoinhibition can identify rare driver mutations and advise pharmacology
  2. Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum
  3. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2020, Jan; 34(1): 16-29.
  1. 5.   Proline metabolism and cancer
  2. Phang, J. M.; Liu, W.
  3. Frontiers in Bioscience-Landmark. 2012, Jan; 17: 1835-1845.
  1. 6.   Eph/ephrin signaling in cell-cell and cell-substrate adhesion
  2. Singh, A.; Winterbottom, E.; Daar, I. O.
  3. Frontiers in Bioscience-Landmark. 2012, Jan; 17: 473-497.
  1. 7.   High Throughput Screening of Normal and Neoplastic Tissue Samples
  2. Erickson, H. S.; Gannot, G.; Tangrea, M. A.; Chuaqui, R. F.; Gillespie, J. W.; Emmert-Buck, M. R.
  3. Combinatorial Chemistry & High Throughput Screening. 2010, Mar; 13(3): 253-267.
  1. 8.   Stem cells as a therapeutic target for diabetes
  2. Mishra, P. K.; Singh, S. R.; Joshua, I. G.; Tyagi, S. C.
  3. Frontiers in Bioscience-Landmark. 2010, Jan; 15: 461-477.
  1. 9.   Hairpin- and cruciform-mediated chromosome breakage: causes and consequences in eukaryotic cells
  2. Lobachev, K. S.; Rattray, A.; Narayanan, V.
  3. Frontiers in Bioscience. 2007, May; 12: 4208-4220.
  1. 10.   A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum
  2. Stahl-Hennig, C.; Eisenblatter, M.; Franz, M.; Stoiber, H.; Tenner-Racz, K.; Suh, Y. S.; Jasny, E.; Falkensammer, B.; Ugucchioni, M.; Georgsson, G.; Baroni, C.; Dierich, M. P.; Lifson, J. D.; Steinman, R. M.; Uberla, K.; Racz, P.; Ignatius, R.
  3. Frontiers in Bioscience. 2007, Jan; 12: 2107-2123.
  1. 11.   Marine pharmacology in 2003-2004: Anti-tumour and cytotoxic compounds
  2. Mayer, A. M. S.; Gustafson, K. R.
  3. European Journal of Cancer. 2006, Sep; 42(14): 2241-2270.
  1. 12.   Antibody-based inhibitors of HIV infection
  2. Choudhry, V.; Zhang, M. Y.; Dimitrova, D.; Prabakaran, P.; Dimitrov, A. S.; Fouts, T. R.; Dimitrov, D. S.
  3. Expert Opinion on Biological Therapy. 2006, MAY; 6(5): 523-531.
  1. 13.   Natural products from marine invertebrates and microbes as modulators of antitumor targets
  2. Newman, D. J.; Cragg, G. M.
  3. Current Drug Targets. 2006, MAR; 7(3): 279-304.
  1. 14.   TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer
  2. Cretney, E.; Shanker, A.; Yagita, H.; Smyth, M. J.; Sayers, T. J.
  3. Immunology and Cell Biology. 2006, FEB; 84(1): 87-98.
  1. 15.   KSR regulation of the Raf-MEK-ERK cascade
  2. Ritt, D. A.; Daar, I. O.; Morrison, D. K.
  3. Regulators and Effectors of Small Gtpases: Ras Family. 2006; 407 : 224-237.
  1. 16.   The RIO kinases: An atypical protein kinase family required for ribosome biogenesis and cell cycle progression
  2. Laronde-Leblanc, N.; Wlodawer, A.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2005, DEC 30; 1754(1-2, Sp. Iss.): 14-24.
  1. 17.   Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain
  2. Jaroniec, C. P.; Kaufman, J. D.; Stahl, S. J.; Viard, M.; Blumenthal, R.; Wingfield, P. T.; Bax, A.
  3. Biochemistry. 2005, DEC 13; 44(49): 16167-16180.
  1. 18.   The dog and its genome
  2. O'Brien, S. J.
  3. Nature. 2005, DEC 8; 438(7069): 740-740.
  1. 19.   Computational intelligence, bioinformatics and computational biology: A brief overview of methods, problems and perspectives
  2. Kasabov, N.; Sidorov, I. A.; Dimitrov, D. S.
  3. Journal of Computational and Theoretical Nanoscience. 2005, DEC; 2(4): 473-491.
  1. 20.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 21.   Genomic inferences from Afrotheria and the evolution of elephants
  2. Roca, A. L.; O'Brien, S. J.
  3. Current Opinion in Genetics & Development. 2005, DEC; 15(6): 652-659.
  1. 22.   A family portrait of the RIO kinases
  2. Laronde-Leblanc, N.; Wlodawer, A.
  3. Journal of Biological Chemistry. 2005, NOV 11; 280(45): 37297-37300.
  1. 23.   The role of IL-6 and STAT3 in inflammation and cancer
  2. Hodge, D. R.; Hurt, E. M.; Farrar, W. L.
  3. European Journal of Cancer. 2005, NOV; 41(16): 2502-2512.
  1. 24.   Cell cycle sibling rivalry - Cdc2 vs. Cdk2
  2. Kaldis, P.; Aleem, E.
  3. Cell Cycle. 2005, NOV; 4(11): 1491-1494.
  1. 25.   Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail
  2. Wyss, S.; Dimitrov, A. S.; Baribaud, F.; Edwards, T. G.; Blumenthal, R.; Hoxie, J. A.
  3. Journal of Virology. 2005, OCT; 79(19): 12231-12241.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel